Oil is on the rise again amid flaring tensions in the Middle East. That's not remotely shocking, given the Strait of Hormuz's importance. The Strait is effectively closed right now.

There's a saying that Wall Street climbs a wall of worry. One of the big worries right now is around inflation, which is running hotter than the Federal Reserve would like, at least partly thanks to ...

There are plenty of good artificial intelligence (AI) stocks available to investors these days, and if you've got $1,000 to invest right now, you've likely thought about buying Micron Technology ...

AbbVie (NYSE: ABBV) was spun off from Abbott (NYSE: ABT) in 2013. That's an important fact to keep in mind when you look at AbbVie's Dividend King status. Technically, it hasn't increased its dividend ...

Over the last couple of years, Super Micro Computer (NASDAQ: SMCI) has dealt with some notable headwinds that have affected perceptions around the company.

Obviously, nobody owns a functioning crystal ball. So, take any predictions about someone else's future actions with a grain of salt. You can make educated guesses, however, based on a person's past ...

Space Exploration Technologies (NASDAQ: SPCX) took off like one of its Falcon 9 rockets in the immediate days following its initial public offering on June 12, 2026. That IPO was one for the record ...

Although Warren Buffett no longer heads Berkshire Hathaway, its stock trades and positions continue to attract plenty of attention.

AstraZeneca AZN announced that the European Commission (EC) has approved Etcamah (camizestrant) in combination with a CDK4/6 inhibitor for the first-line treatment of a certain type of breast cancer.

Ellington Financial Inc. (NYSE: EFC) (the 'Company') today announced that it will release financial results for the quarter ended June 30, 2026 after market close on Thursday, August 6, 2026.

Ethereum (CRYPTO: ETH) badly needs a new story, and its founder, Vitalik Buterin, is intent on creating exactly that. Buterin dropped a fresh draft of the network's long-term roadmap on July 4, ...

In recent trading, shares of Omega Healthcare Investors, Inc. (Symbol: OHI) have crossed above the average analyst 12-month target price of $32.62, changing hands for $32.66/share.